Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Lotte Rijken, Msc. l.rijken@amsterdamumc.nl


Kak Khee Yeung, MD, PhD +31 6 14278725
k.yeung@amsterdamumc.nl


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

Recruiting

Open to: ALL

Age: 40.0 - 90.0

Medical Conditions

Aneurysm Abdominal
Peripheral Arterial Disease


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Oct 2023 May 2029

Publications

"Rijken L, Zwetsloot S, Smorenburg S, Wolterink J, Isgum I, Marquering H, van Duivenvoorde J, Ploem C, Jessen R, Catarinella F, Lee R, Bera K, Buisan J, Zhang P, Dias-Neto M, Raffort J, Lareyre F, Muller C, Koncar I, Tomic I, Zivkovic M, Djuric T, Stankovic A, Venermo M, Tulamo R, Behrendt CA, Smit N, Schijven M, van den Born BJ, Delewi R, Jongkind V, Ayyalasomayajula V, Yeung KK. Developing Trustworthy Artificial Intelligence Models to Predict Vascular Disease Progression: the VASCUL-AID-RETRO Study Protocol. J Endovasc Ther. 2025 Feb 7:15266028251313963. doi: 10.1177/15266028251313963. Online ahead of print."; "39921236"

OBSERVATIONAL

Intervention Type : OTHER
Intervention Description : No intervention, retrospective study

Intervention Arm Group : Abdominal Aortic Aneurysm patients;Peripheral Arterial Disease patients;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Oxford University Hospitals
    Oxford

Kak Khee Yeung, MD, PhD +31 6 14278725
k.yeung@amsterdamumc.nl


Lotte Rijken, Msc. l.rijken@amsterdamumc.nl



The study is sponsored by Amsterdam UMC, location VUmc and is in collaboration with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Technical University of Twente; Universidade do Porto; Centre Hospitalier Universitaire de Nice; Stichting Allai; Faculty of Medicine, University of Belgrade; Brightfish Be; Hospital District of Helsinki and Uusimaa; University of Bergen; Asklepios Kliniken Hamburg GmbH; University of Oxford; VINÄŚA INSTITUTE OF NUCLEAR SCIENCES Belgrado.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT06206369
Last updated 04 January 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.